ABEL SAENZ: Open Payments
NPI 1053317511 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,482 in 32 payments from 13 companies in 2025. Trend: 2023 $486 · 2024 $1,053 · 2025 $1,482
Food & beverage: $1,482
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK INC. | 7 | $343 |
| CVRx, Inc. | 2 | $200 |
| AstraZeneca Pharmaceuticals LP | 5 | $183 |
| Novo Nordisk Inc | 3 | $168 |
| Lilly USA, LLC | 1 | $125 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $121 |
| Abbott Laboratories | 4 | $109 |
| ABIOMED | 1 | $97 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Amgen Inc. | 2 | $32 |
Products named: Barostim Neo System, Wegovy, ZEPBOUND, LifeVest, LOKELMA, AMVIA EDGE, FARXIGA, JOT DX.
Industry payments across TX — which companies pay providers there.
